PI Industries secures registration for indigenous insecticide Pioxaniliprole
- PI Industries secured registration for Pioxaniliprole, India's first indigenous insecticide
- Approval granted under Insecticides Act, 1968 for TIM and FIM categories
- Product branded as 'Pioxazon' targets the domestic market exclusively
- Development reflects decade-long research effort by the company

*this image is generated using AI for illustrative purposes only.
PI Industries Limited has secured registration for Pioxaniliprole, India’s first indigenously discovered insecticide, under section 9(3) of the Insecticides Act, 1968. The approval, granted by the Ministry of Agriculture & Farmers Welfare, covers the Technical Intermediate Material (TIM) and Formulated Intermediate Material (FIM) categories.
The registration committee approved the molecule on September 10, 2026, with the decision published on September 21, 2026. The company disclosed the development pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Product Details
Pioxaniliprole, branded as 'Pioxazon', represents a decade of research by the company. It is currently approved for the domestic market only. The company plans to launch the product in India soon to address crop productivity challenges.
| Particulars | Details |
|---|---|
| Product Name | Pioxaniliprole (Branded as 'Pioxazon') |
| Registration Date | September 21, 2026 |
| Category | Insecticide |
| Market Focus | Domestic |
Strategic Significance
The approval underscores PI Industries' evolution into a global-scale innovator in Agri Sciences. As an indigenously developed molecule, Pioxaniliprole reduces dependency on imported active ingredients and supports the country's agricultural innovation journey.
Historical Stock Returns for PI Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.90% | +2.78% | -7.68% | -20.69% | -37.35% | 0.0% |
When does PI Industries plan to initiate the registration process for Pioxaniliprole in key international markets beyond India?
How is the launch of Pioxazon expected to impact PI Industries' revenue mix and gross margins compared to its existing generic product portfolio?
What specific pest resistance challenges in Indian agriculture is Pioxaniliprole designed to overcome, and how does this differentiate it from current market offerings?


































